LALI QURKHULI
Lali Qurkhuli
Therapist
Doctor Lali Kurkhuli is a specialist in Internal Medicine and a member of the Georgian and European Respiratory Associations. She has gained extensive experience at the Tbilisi Medical Academy, medical diagnostic centers, and the Cardiology Center in the field of computerized spirography. Mrs. Kurkhuli has participated in numerous international congresses and research projects. She is the author of seven medical articles and is actively involved in clinical research in the field of pulmonology, including studies on severe eosinophilic asthma and chronic obstructive pulmonary disease (COPD).
Office Hours:
Education
2005 - Tbilisi, Georgia: Continuing Medical Education Program “Pneumonia”
2005 - Tbilisi, Georgia: “The Role of Gender in Health and Medical Care”
2004 - Moscow, Russia: “Clinical Physiology During Exercise and Respiratory Failure in Pulmonary Diseases”
2001 - Tbilisi, Georgia: State Certification in “Internal Medicine”
1998 - Moscow, Russia: Qualification in “Functional Pulmonary Diagnostic Methods”
1979 - Tbilisi, Georgia: Clinical Residency in “Internal Medicine”
1967-1974 - Tbilisi State Medical Institute, Diploma A-1 No.145279
Professional Experience
1973-1974 - Internship at the Medical Department of Rustavi Metallurgical Plant
1974-1977 - Chief Physician, Patardzeuli Hospital
1977-1979 - Tbilisi Institute for Advanced Medical Training, Clinical Residency in “Internal Medicine”
1979-1993 - Internal Medicine Physician, Clinic of the Tbilisi Institute for Advanced Medical Training
1993-2003 - Clinic of Tbilisi Medical Academy, Department of Internal Medicine, Internal Medicine Physician
1999-2012 - Medical Diagnostic Center, Department of Functional Diagnostics, Physician in the Computerized Spirography Unit
2012-Present - LLC “Diagnostic Service,” Physician in the Computerized Spirography Laboratory
2020-Present - Cito Medical Center
2022-Present - LLC “Acad. G. Chapidze Emergency Cardiology Center,” Computerized Spirography Laboratory, Consultant
Clinical Research in Pulmonology
2025-Present - Sub-Investigator, Phase III extension study evaluating the long-term safety and tolerability of Dexpramipexole in patients with severe eosinophilic asthma (EXHALE-5)
2024-Present - Sub-Investigator, Randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of Dexpramipexole in patients with severe eosinophilic asthma (EXHALE-2)
2023-Present - Sub-Investigator, 52-week randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of two doses of CHF6001 DPI in patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis
2014-2015 - Sub-Investigator, Randomized, double-blind, multicenter study evaluating the efficacy and safety of intravenous and oral Solithromycin (CEM-101) compared with intravenous followed by oral Moxifloxacin in patients with community-acquired pneumonia (CE01-301)
2014-2015 - Sub-Investigator, Multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of Pulmaquin® in patients with non-cystic fibrosis bronchiectasis and chronic lung infections caused by Pseudomonas aeruginosa, including a 28-day open-label extension period (ORBIT-4)
2010-2013 - Sub-Investigator, Study of an anticholinergic agent in patients with COPD using two different inhalation devices